Cysteine sulfinic acid or S-sulfinylation is an oxidative post-translational modification (OxiPTM) that is known to be involved in redox-dependent regulation of protein function but has been historically difficult to analyze biochemically. To facilitate the detection of S-sulfinylated proteins, we demonstrate that a clickable, electrophilic diazene probe (DiaAlk) enables capture and site-centric proteomic analysis of this OxiPTM. Using this workflow, we revealed a striking difference between sulfenic acid modification (S-sulfenylation) and the S-sulfinylation dynamic response to oxidative stress, which is indicative of different roles for these OxiPTMs in redox regulation. We also identified > 55 heretofore-unknown protein substrates of the cysteine sulfinic acid reductase sulfiredoxin, extending its function well beyond those of 2-cysteine peroxiredoxins (2-Cys PRDX1-4) and offering new insights into the role of this unique oxidoreductase as a central mediator of reactive oxygen species-associated diseases, particularly cancer. DiaAlk therefore provides a novel tool to profile S-sulfinylated proteins and study their regulatory mechanisms in cells.
T he sulfur atom of cysteine has the ability to assume many different oxidation states, such as sulfhydryl (-SH, -2), sulfenic acid (-SOH, 0), sulfinic acid (-SO 2 H, + 2) and sulfonic acid (-SO 3 H, + 4), which exhibit distinct chemical properties and biological reactivity 1 (Fig. 1a) . OxiPTMs, such as sulfenic acid 2 , were long overshadowed by other canonical representatives, such as disulfides (-S-S-, -1), but recent advances in chemoproteomics 3, 4 have enabled the identification of this cysteine oxoform in a substantial number of proteins 5, 6 , thus fundamentally changing perspectives on its role in physiology [7] [8] [9] and disease 10 . The biological function of sulfinic acid has also been hotly debated, largely owing to a general consensus that this modification cannot be reduced under physiological conditions 11 . This observation led many to conclude that sulfinic acid formation in proteins is irreversible or caused by random cysteine oxidation during isolation. However, this idea was challenged by the discovery that peroxiredoxin enzymes are reversibly inactivated by oxidation of the catalytic cysteine to sulfinic acid in cells 12, 13 . Soon after, an ATP-dependent enzyme with sulfinic acid reductase activity, sulfiredoxin (SRX), was isolated from yeast 14 , and a human homolog was subsequently identified 15 . To date, peroxiredoxin isoforms 1-4 (PRDX1-4) are the only confirmed SRX substrates 16 , thus prompting interesting questions concerning the possibility of other targets and the broader role of this unique oxidoreductase in redox regulation. Individual studies have identified a functional role for sulfinic acid modification or S-sulfinylation in a growing list of proteins 17 , including the Parkinson's disease protein DJ-1 (refs 18, 19 ). Despite its regulatory potential 20 and association with diseases 21 linked to the generation of reactive oxygen species 22 , including cancer [23] [24] [25] , the scope, dynamics and function of sulfinic acid are essentially unknown, owing to major challenges of detection.
The weak nucleophilicity of the sulfur in sulfinic acid, compared with that of the more abundant and reactive thiol(ate), has limited the development of general methods for biochemical analysis. Antibodies have been generated for monitoring sulfinic acid but have limited affinity and specificity 26 . Alternatively, a difference of + 32 Da has been used to detect sulfinic acid by mass spectrometry; however, this approach is plagued by oxidation during lengthy sample preparation 27 and the existence of other modifications with the same nominal mass shift, such as S-sulfhydration (-SSH). Acidic conditions can be used to favor the reaction of sulfinic acid with N-maleimides, but thiols and other biofunctional groups remain vulnerable to irreversible labeling 28 . To exploit the unique properties of S-sulfinylated proteins, chemical methods based on electrophilic nitrogen species (ENS) have also been developed 29 (Fig. 1b ). ENS are soft electrophiles in which the nitrogen carries a partial positive charge. A soft nitrogen electrophile may react with both thiol and sulfinic acid, but the stability of the resulting adduct depends upon the nature of the sulfur nucleophile. Attack of a thiol on the electrondeficient nitrogen center yields a labile sulfenyl amide, which is readily converted back to the thiol by common reducing agents, such as dithiothreitol (DTT). In contrast, the addition of sulfinic acid to the same species yields a stable sulfonamide. Our initial effort, termed sulfinic acid nitroso ligation (SNL; Fig. 1c ) supported the validity of the ENS approach by demonstrating efficient addition of electrondeficient C-nitroso compounds to sulfinic acids 29, 30 ( Supplementary  Fig. 1a ). SNL exhibits high selectivity toward sulfinic acid, but in cases in which the thiol is sterically hindered, the labile sulfenamine intermediate can rearrange, thus yielding a nonreducible sulfoxide adduct ( Supplementary Fig. 1b ). This side reaction can be ameliorated by preblocking thiols, and a biotinylated derivative, termed NO-Bio ( Supplementary Fig. 1c ), has been successfully elaborated for several applications 30 ; however, complex mass spectrometric Articles NATURe CheMiCAl BiOlOgy fragmentation patterns render the probe incompatible with sitecentric proteomics. A subsequent study 31 used S-nitrosothiols to profile sulfinic acid (Fig. 1d) ; however, this reaction produces the aggressive electrophilic oxidant nitroxyl (HNO) as a byproduct. HNO generation precludes quantitative conversion of sulfinic acid to the thiosulfonate and converts thiols to sulfinamides and sulfinic acid 32 (Fig. 1d and Supplementary Fig. 2 ). Despite their limitations, these early approaches have revealed noteworthy candidate S-sulfinylated proteins associated with diverse cellular pathways, thus suggesting a more complex role for this OxiPTM in biology while also highlighting the need for more advanced methods to detect and quantify S-sulfinylated proteins from cells. 
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Results
Electrophilic diazenes form stable sulfonamide adducts. Sulfinic acid has a pK a of ~2 and is deprotonated at physiological pH. Accordingly, the precise chemical target is the sulfinate anion (-SO 2   -) , an ambident nucleophile. The key challenge in sulfinate detection is the stronger nucleophilicity of abundant competing thiolates. ENS offer a novel solution to this problem because the attack of a sulfinate on the electron-deficient nitrogen center yields a stable sulfonamide, whereas a thiolate yields a labile sulfenamide ( Fig. 1b ). However, as outlined above, both C-and S-nitroso ENS have issues that limit their utility in chemoproteomics. We therefore examined two new classes of ENS, diazonium salts ( Fig. 1e ) and diazenes ( Fig. 1f ), as potential solutions for protein sulfinic acid detection.
We first selected 4-nitrobenzenediazonium tetrafluoroborate (NDF) as a prototype for an electron-poor diazonium salt. When mixed with NDF in equal amounts at pH 5, N-Fmoc cysteine sulfinic acid reacted rapidly, yielding an orange diazosulfone product ( Supplementary Fig. 3a ). Under identical conditions, N-Fmoc cysteine also underwent facile reaction with NDF, forming a diazosulfenyl derivative ( Supplementary Fig. 3b ). At basic pH, the diazonium cation can also be conjugated to tyrosine residues 33 . Indeed, NDF formed adducts with a single-cysteine variant of thiol peroxidase, C64S C82S (C64,82S) Gpx3 (ref. 34 ), even when the remaining thiol (C36) was preblocked by methyl methanethiosulfonate ( Supplementary Fig. 4 ). The known reversibility of sulfur adducts and cross-reactivity with tyrosines thus excluded application of diazonium salts to analysis of sulfinic acid.
Next, we tested organic diazene compounds for their utility in sulfinic acid detection (Fig. 2 ). The first diazene examined was tetramethylazodicarboxamide (TMAD; Fig. 2a ). To evaluate small-molecule or protein cysteine sulfinic acid labeling, we analyzed reaction mixtures by liquid chromatography-tandem mass spectrometry (LC-MS or intact-protein MS). TMAD showed promising reactivity with N-Fmoc cysteine sulfinic acid ( Supplementary Fig. 5 ) and a protein model (C64,82S Gpx3-SO 2 H; ref. 30 and Supplementary  Fig. 6 ), thus forming the expected sulfonamide adduct. However, the reaction of TMAD with Gpx3-SO 2 H was not quantitative (~25%; Fig. 2a and Supplementary Fig. 6a ). Hypothesizing that this observation was due to the low electrophilicity of the nitrogen center, we tested the effect of electrophilic substitution on TMAD reactivity ( Fig. 2a and Supplementary Fig. 6a ). Diisopropyl azodicarboxylate and di-t-butyl azodicarboxylate (DBAD) quantitatively converted Gpx3-SO 2 H to the sulfonamide adduct, whereas the yield of diethyl azodicarboxylate was only 48% ( Fig. 2a and Supplementary Fig. 6a ). The reaction of DBAD with N-Fmoc cysteine sulfinic acid gave full conversation to sulfonamide product in minutes ( Supplementary  Fig. 7a ). Interestingly, we noted that a single t-butyloxy carbonyl (BOC) group was lost from the sulfonamide adduct in a timedependent manner, thus affording a monosubstituted product that was stable ( Supplementary Fig. 7b ); similar observations were made with Gpx3-SO 2 H (23,003 versus 22,903 m/z; Supplementary  Fig. 6b ,c). Owing to its superior reactivity, DBAD was selected for further development.
Validating DiaAlk and DiaFluo as sulfinic acid probes.
To facilitate detection and enrichment of labeled targets, we then synthesized a 'clickable' alkyne derivative of DBAD, termed DiaAlk (5 ; Fig. 2b and Supplementary Note). With addition of the single alkyne tag, DBAD is converted into an asymmetrical molecule and, in principle, the sulfinic acid can attack at both positions of the N= N. Critically, analysis of the reaction between DiaAlk and sulfinic acid indicated that attack occurs at the less hindered nitrogen atom of the diazene, thus generating a sulfonamide adduct and leading to a mass increase of 298 Da ( Fig. 2c and Supplementary Fig. 8a ). The secondorder rate constant for the reaction of DiaAlk and N-Fmoc cysteine sulfinic acid in neutral buffer was measured as 2.5 × 10 3 M −1 min −1 ( Supplementary Fig. 8b ). Hydrolysis of the initial DiaAlk sulfonamide adduct ('double BOC'), analogously to DBAD hydrolysis, yielded a monosubstituted product ('single BOC') with retention of the alkyne tag ( Supplementary Fig. 8a ). Likewise, intact-protein MS demonstrated quantitative labeling of Gpx3-SO 2 H by DiaAlk, and this was followed by time-and pH-dependent cleavage of the BOC group ( Fig. 2d ). Analysis of C64,82S Gpx3-SH after treatment with DiaAlk and then DTT confirmed that the diazene-based probe does not form a stable adduct with Gpx3 C36 in its thiol form ( Fig. 2e ). The stability of the N-Fmoc cysteine and Gpx3-DiaAlk adducts was also verified by exposure to the conditions used during proteomic sample preparation ( Supplementary Figs. 8c and 9 ). Gpx3 C36 was further confirmed as the site of adduct formation by tryptic digestion and LC-MS/MS analysis and represented > 95% of spectral counts from DiaAlk labeling ( Supplementary Fig. 10 ).
The specificity of DiaAlk was also substantiated by MS and immunoblot analysis of DJ-1 (bearing a H 2 O 2 -sensitive C106 and two other redox-active cysteines, C46 and C53; Supplementary  Fig. 11 ) and phage shock protein E (PspE; bearing a single hindered cysteine, C67; Supplementary Fig. 12 ). To visualize S-sulfinylation, we exposed proteins to H 2 O 2 (or left them untreated), incubated them with DiaAlk, subjected them to Cu(i)-catalyzed azide-alkyne cycloaddition with azide-biotin and analyzed them by streptavidinhorseradish peroxidase (Strep-HRP) immunoblotting ( Fig. 2f-h ). When benchmarked against other methods, including use of commercially available antibodies 26 that recognize sulfinic and sulfonic acid in select peptide sequences, and our earlier NO-Bio probe 30 , the DiaAlk method had superior sensitivity ( Supplementary Fig. 13 ). DiaAlk labeling of proteomes from HeLa lysates was dependent on redox, dose and time, as expected ( Supplementary Fig. 14) .
Finally, we synthesized a fluorescent derivative of DiaAlk, DiaFluo (6 ; Fig. 3a and Supplementary Note), for visualization of protein S-sulfinylation in mammalian cells. HeLa cells were exposed to H 2 O 2 (or untreated), fixed, blocked with N-ethylmaleimide, probed with DiaFluo and imaged by fluorescence microscopy. A clear peroxide-dependent increase in fluorescence intensity was observed, which was localized throughout the cell, whereas controls minus DiaFluo exhibited only background signal (Fig. 3b ). These results establish the utility of DiaAlk as a robust probe for labeling sulfinic acid in a variety of protein microenvironments (e.g., surface exposed, charged and buried), and of its complementary analog DiaFluo in fluorescence imaging.
General strategy to discover new S-sulfinylated proteins.
Having validated the selectivity of DiaAlk in small-molecule and protein sulfinic acids, we next set out to identify novel S-sulfinylation targets through two approaches. First, we investigated the proteome S-sulfinylation resulting from addition of exogenous H 2 O 2 to A549 and HeLa cells, by using our established chemoproteomic workflow 3, 4 . These analyses are designed to explicitly delineate proteomic cysteines capable of reacting with H 2 O 2 and undergoing sulfinic acid modification, an event known as 'hyperoxidation' . Second, we used chemoproteomics to map differential S-sulfinylation in SRX-deficient (Srx -/-) and SRX-replete (Srx +/+ ) mouse embryonic fibroblast (MEF) cells 35 which we classify as 'SRX-regulated' cysteines. The latter comparison identifies SRX-dependent changes in S-sulfinylation, with the possibility of revealing new biology specific to this reductase.
Chemoproteomic analysis of H 2 O 2 -sensitive cysteines.
Focusing initially on cysteines that undergo hyperoxidation, we used DiaAlk to profile S-sulfinylation caused by treatment of cells with H 2 O 2 (1 mM, 15 min; Fig. 4a ). Native proteomes obtained from A549 or HeLa cells were blocked with 4,4´-dipyridyldisulfide (4-DPS) to prevent thiol-mediated probe consumption, labeled with DiaAlk (5 mM, 2 h) and then digested with trypsin. Tagged peptides from Articles NATURe CheMiCAl BiOlOgy control and H 2 O 2 -treated samples were conjugated to light and heavy azide-biotin functionalized with a photocleavable linker (Az-UV-biotin) via Cu(i)-catalyzed azide-alkyne cycloaddition, combined, purified by streptavidin and released by photocleavage of the biotin linker. Liberated peptides modified with DiaAlk-triazohexanoic acid were analyzed by LC-MS/MS (Fig. 4b,c ). In aggregate, we identified and quantified 387 probe-tagged S-sulfinylated sites on 296 proteins from A549 and HeLa cells; 19.3% of sites (75 sites) were common to both cell lines ( Fig. 4d ,e and Supplementary Dataset 1). Identified among these hits were known sites of S-sulfinylation including PRDX6 C47 (ref. 36 ), GAPDH C152 (ref. 16 ) and PTPN1 (also known as PTP1B) C215 (ref. 37 ), as were a cohort of novel S-sulfinylation events at functionally important sites, such as active sites (e.g., ALDH1L1 C707; SQRDL C201; and ACAT1 C126), metal-binding sites (e.g., NDUFS1 C92; AOX1 C44; and DPYD C82) and disulfide bonds (e.g., EFNB2 C62 and PDIA3 C85 and C92). Bioinformatic analysis indicated their distribution across all major subcellular compartments ( Supplementary Fig. 15a ). Of note, we found that 47.3% of S-sulfinylated proteins were highly enriched in exosomes, which protect cells against stress through removal and/or transport of oxidized proteins 38,39 . S-sulfinylated proteins were also substantially enriched in diverse biological processes and pathways, including oxidation-reduction, cell-cell adhesion, RNA processing, glycolysis, protein import into the nucleus and fatty-acid beta-oxidation ( Supplementary Fig. 15b ,c). To examine the chemoselectivity of DiaAlk at the broadest possible level, we also searched our proteomic data for potential cross-reactivity with other nucleophilic residues ( Supplementary Fig. 16a ). Importantly, cysteine sulfinic acid accounted for > 99.9% of all spectral counts ( Supplementary  Fig. 16b ). A blind search for post-translational modifications also 
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NATURe CheMiCAl BiOlOgy did not identify unwanted DiaAlk adducts. These data demonstrate that DiaAlk selectively maps known and novel S-sulfinylation sites of functional importance in human proteomes. Because dynamic sites of S-sulfinylation may function as 'sensors' of stress, we also quantified the H 2 O 2 -dependent fold change in oxidation (ratios of H 2 O 2 to control (R H2O2/Ctrl ) or heavy to light (R H/L ); Fig. 4d , Supplementary Fig. 17 and Supplementary Dataset 1). Identified sites often exhibited differential responses to H 2 O 2 depending on cell type ( Fig. 4f ). For example, S-sulfinylation of PRDX6 C47 dramatically increased in HeLa cells in response to H 2 O 2 treatment (R H/L = 8.69), whereas this change was relatively small in A549 cells (R H/L = 3.00). In contrast, S-sulfinylation of GAPDH C152 exhibited higher sensitivity toward H 2 O 2 in A549 cells (R H/L = 11.98) than in HeLa cells (R H/L = 1.52). Separately from these oxidation events, a small fraction of cysteine sulfinic acids (5.0% and 0.45% of the A549 and HeLa S-sulfinylomes, respectively), such as C192 of glutathione S-transferase omega 1 (GSTO1), exhibited a substantial decrease in S-sulfinylation after H 2 O 2 treatment. These data suggest susceptibility to further oxidation to sulfonic acid, which would appear as a loss of signal. Although it is often suggested that sulfenyl amide formation with the adjacent backbone nitrogen of S216 protects active site C215 against hyperoxidation, we observed PTPN1 as highly S sulfinylated in both cell types (R H/L = 5.90 and = 4.98 in A549 and HeLa, respectively). To independently validate site-specific, H 2 O 2 -induced S-sulfinylation of PTPN1, we expressed epitope-tagged constructs (wild-type and C215S) in HeLa cells labeled in situ with DiaAlk (5 mM, 2 h); lysates were immunoprecipitated, reacted with azide-biotin and visualized by streptavidin immunoblotting. This analysis confirmed DiaAlk labeling of wild-type PTPN1, whereas mutation of C215 abrogated labeling, as expected ( Fig. 4g ). S-sulfinylation and S-sulfenylation (-SOH) 17 , we next asked whether these OxiPTMs might exhibit similar target profiles. Here, we conducted a quantitative analysis of the S-sulfenylome from both A549 and HeLa cells under identical H 2 O 2 stress, by using our recently described chemoproteomic method 3, 4 . In total, we identified and quantified 1,173 and 1,098 S-sulfenylation sites in A549 and HeLa cells, respectively ( Fig. 5 and Supplementary Dataset 2). Approximately 40% of S-sulfinylated sites were identified in the corresponding S-sulfenylome dataset (Fig. 5a ), thus indicating excellent overlap, given the lineage of these OxiPTMs and the comparatively transitory nature of sulfenic acids. Of particular interest, we noted that oxidative stress induced distinct fold-change dynamics in both OxiPTMs. For example, most S-sulfinylation sites in A549 cells (91.7%) were unchanged after H 2 O 2 stimulation (0.67 ≤ R H/L ≤ 1.5), whereas 60.3% of the corresponding S-sulfenylome underwent substantial fold changes (> 1.5; Fig. 5b ). In contrast, most S-sulfinylation (84.1%) and S-sulfenylation (95.1%) sites in HeLa cells were unchanged (0.67 ≤ R H/L ≤ 1.5; Fig. 5b ), in agreement with elevated basal levels of H 2 O 2 production in this particular cancer cell line 40 . In HeLa cells, the most highly downregulated S-sulfenylation event was the peroxidatic cysteine of PRDX6 (C47), a result consistent with hyperoxidation to sulfinic acid ( Fig. 5a ). Similar reciprocity was observed at the redox-sensitive cysteine of GAPDH C152 (Fig. 5a ). The finding that S-sulfenylation is considerably more dynamic is supported by mechanistic studies 41 indicating that oxidation of a thiolate to sulfenic acid occurs more readily than oxidation of sulfenic to sulfinic acid (reflecting the intrinsic decrease in sulfur nucleophilicity) and by cell-based studies highlighting the ability of antioxidant systems to protect cysteines from hyperoxidation 7, 13, 15, 35 .
Chemoproteomics reveals new substrates of sulfiredoxin.
To complement our H 2 O 2 -sensitivity data, we next examined SRXregulated changes in S-sulfinylation. For these studies, we evaluated turnover of the S-sulfinylome in Srx +/+ and Srx -/-MEFs 35 by using an established 'recovery' method 14, 16 . Cells were exposed to H 2 O 2 stress to induce Srx expression in wild-type MEFs ( Supplementary  Fig. 18 ) and harvested for chemoproteomic analysis or placed in H 2 O 2 -free culture medium and allowed to recover for 2 h (Fig. 6a ). In principle, SRX-targeted sulfinic acids should be turned over (i.e., reduced) in Srx +/+ but not Srx -/cells. Native proteomes obtained from Srx +/+ and Srx -/-MEFs were blocked with 4-DPS, labeled with DiaAlk (5 mM, 2 h) and digested into tryptic peptides. The resulting peptide mixtures, with and without recovery, were conjugated to heavy and light Az-UV-biotin reagents, respectively. DiaAlktagged peptides were then affinity purified on streptavidin, photoreleased and analyzed with LC-MS/MS. In total, we identified and quantified 680 S-sulfinylated sites (521 proteins) and 407 sites (339 proteins) in Srx +/+ and Srx -/-MEFs, respectively ( Fig. 6b and Supplementary Dataset 3). Approximately 80% of protein sulfinic acids were not turned over in Srx +/+ MEFs (0.67 < R H/L < 1.5; Fig.  6c ). For example, sulfinic acid forms of PRDX6 (C47) and GAPDH (C152) remained unchanged in Srx +/+ MEFs during the recovery period (Fig. 6c , inset), thus indicating that these sites are not reduced by SRX. The observation that S-sulfinylation of PRDX6 and GAPDH is not repaired by SRX is consistent with earlier biochemical findings 16 and independently validates our method. The overall level of S-sulfinylation was also increased in Srx -/-MEFs during the recovery period ( Supplementary Dataset 3) , thereby affirming the susceptibility of Srx-deficient cells to acute oxidative stress 21, 35 . Because tryptic peptides bearing the catalytic cysteines of established SRX substrates PRDX 1-4 were too long and hydrophobic for robust chemoproteomic analysis, we next examined whether DiaAlk was able to detect changes in S-sulfinylation in one of these sentinel peroxidases, PRDX1, by immunoblotting. 
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NATURe CheMiCAl BiOlOgy workflow and labeled with DiaAlk (5 mM, 2 h); proteomes were click modified with azide-biotin, captured with streptavidin and visualized by immunoblotting. This analysis verified the ability of DiaAlk to detect SRX-dependent changes in S-sulfinylation of PRDX1, whereas GAPDH, as a negative control, showed no change, as expected ( Fig. 6d ).
In total, our chemoproteomic analyses enabled site-specific and quantitative comparison of turnover at 249 S-sulfinylation sites among Srx +/+ and Srx -/-MEFs ( Fig. 6b ). Of these, 59 sulfinic acids on 55 proteins exhibited substantial turnover in Srx +/ + MEFs (R H/L < 0.67) but remained unchanged or increased (R H/L ≥ 1) in Srx -/-MEFs ( Fig. 6e and Supplementary Dataset 3), thus suggesting that they might be substrates of SRX. For example, S-sulfinylation at C164 of the protein tyrosine phosphatase nonreceptor type 12 (PTPN12 (ref. 42 ; also known as PTP-PEST) decreased by half in Srx +/+ MEFs during the recovery period, whereas turnover was not observed in the Srx knockout ( Fig. 6f) ; analogous observations were made for DJ-1 C46 (Fig. 6g ). To substantiate our proteomic discovery of new SRX substrates, S-sulfinylated proteins were incubated with increasing amounts of recombinant SRX 43 , labeled with a biotinylated DiaAlk derivative, BioDiaAlk (7 ; Supplementary Note) and then visualized by streptavidin blotting (Fig. 6h-j ). PTPN12 and DJ-1 exhibited an SRX-dependent decrease in S-sulfinylation, whereas the GADPH control showed no change. To further characterize this biochemical reaction, we used a luminescence assay, ADP-Glo, to monitor the ADP product formed by SRX reduction of sulfinic acid. ATP hydrolysis was observed by SRX in a dose-dependent manner in reactions containing S-sulfinylated PTPN12 and DJ-1 substrates (Fig. 6k ), but not GAPDH ( Supplementary Fig. 19a ), thus further substantiating the results of proteomic and immunoblot analyses. Control experiments verified PRDX2-SO 2 H as an SRX substrate in BioDiaAlk and ATP-hydrolysis assays ( Supplementary Fig. 19a,b) . Moreover, among three S-sulfinylated cysteines mapped onto the actin-regulating redox sensor cofilin 1 (CFL1) 44,45 , only C39-SO 2 H was recovered in Srx +/+ MEFs ( Supplementary Fig. 20a ). To substantiate this finding, we expressed an epitope-tagged version of wildtype CFL1 or the C39A mutant in HEK293T cells and observed that this mutation partially reversed the turnover of S-sulfinylation during recovery ( Supplementary Fig. 20b ). We also observed that H 2 O 2 treatment increased the association of wild-type CFL1 and SRX ( Supplementary Fig. 20c 
NATURe CheMiCAl BiOlOgy SRX-mediated reduction of S-sulfinylation in new targets, indicating that substrate scope extends well beyond 2-Cys PRDX1-4. Finally, another interesting observation from our chemoproteomic analyses is that S-sulfinylation of evolutionarily conserved C92 in the mitochondrial NADH-ubiquinone oxidoreductase NDUS1 was recovered in both Srx +/+ and Srx -/-MEFs, whereas no protein turnover was observed ( Supplementary Fig. 21 ). These findings suggest that the sulfinic acid at this site might be reduced by a yet-to-be discovered reductase in cells, a possibility that merits exploration in future studies.
Discussion
Protein S-sulfinylation is an emergent and complex OxiPTM in biology that still requires chemical biology methods for functional studies. Here, we demonstrated that cysteine sulfinic acid labeling with the alkyne-functionalized electrophilic diazene reporter DiaAlk enables stable covalent modification of S-sulfinylated proteins from mammalian cells. Our chemoproteomic workflow permits site-specific quantification of dynamic fold changes in sulfinylome modifications. The observation that MS/MS spectra of DiaAlk/click-modified peptides contain diagnostic fragment ions further increases the confidence of S-sulfinylated peptide identification. DiaAlk trapping coupled with our chemoproteomic workflow enabled us to robustly quantify sites of protein S-sulfinylation in normal and H 2 O 2 -stressed cells, thus confirming many known, and revealing many new, S-sulfinylated proteins. Increasing evidence indicates that hyperoxidation of a cysteine thiolate is not as rare or as unregulated as previously believed. For example, analysis of soluble proteins from rat liver tissue by gel focusing electrophoresis has indicated that ≥ 5% of cysteine residues exist as -SO 2 H 46 . Our study reports hundreds of previously unknown sites of protein S-sulfinylation. Interestingly, most sites identified in this study did not undergo substantial fold changes in the extent of modification during stress, thus suggesting that S-sulfinylation may exist at high occupancy under basal conditions and ostensibly accumulate over a protein's lifetime, with reduction/ degradation as the rate-limiting step in this cycle. In agreement with this hypothesis, we found that ~50% of S-sulfinylated proteins were enriched in exosomes, which sort and transport oxidized proteins. In contrast, our previous studies 5 and present data indicate a dynamic S-sulfenylome, with > 60% undergoing substantial fold changes during H 2 O 2 stress in A549 cells. Regarding the lineage between sulfenic and sulfinic acid states, our findings can be rationalized from several standpoints. From a chemical perspective, the reaction between a thiolate and H 2 O 2 occurs more readily than reaction with the less nucleophilic sulfur atom in sulfinic acid, and this difference in rate constants has been well documented 2, 41 . From a biological viewpoint, S-sulfinylation may accumulate because of the moderate intrinsic catalytic activity of SRX 11, 15 and the observation that not all protein sulfinic acids appear to be viable substrates for SRX-targeted reduction. With more available biological routes for reduction 2,7 , the S-sulfenylation cycle has the ability to be more dynamic or adaptive, thus supporting different roles for these OxiPTMs in thiol-based redox-regulation and signaling. Of note, not all sites of S-sulfinylation may stem from nonenzymatic oxidation. For example, cysteine oxidase enzymes in plants can oxidize cysteines to sulfinic acid by using oxygen as a cofactor 47 , although whether a similar enzyme function exists in animals is currently unknown.
In addition, we also identified numerous S-sulfinylation sites with substantial fold changes in modification. S-sulfinylation events undergoing the greatest alterations were found to be enriched among functional cysteines (e.g., those involved in metal-binding, active sites and disulfide bonds) and were distributed across all major compartments. S-sulfinylated proteins were also substantially enriched in various biological processes and pathways. For example, we identified that enzymes involved in cell adhesion, which has been reported to be regulated by H 2 O 2 (ref. 48 ), are highly enriched in the S-sulfinylome. In this regard, filamin B, an actin-binding protein that connects cell-membrane constituents to the actin cytoskeleton, was extensively S-sulfinylated at C2501 and C2115. Glycolysis is another important cellular pathway targeted by S-sulfinylation. One particularly intriguing case was identified in phosphoglycerate kinase 1 (PGK1), which coordinates ATP production with onecarbon metabolism and cellular redox regulation. A recent study has indicated that endogenous H 2 O 2 production and oxidative stress leads to mitochondrial translocation of PGK1, such that it phosphorylates alternative substrates 49 . Among the seven cysteines in PGK1, we found that C50 exclusively underwent S-sulfinylation during stress. Given this correlation, we speculate that oxidation of C50 might mediate PGK1 translocation and/or modulate kinase activity. However, the precise role of S-sulfinylation remains to be uncovered.
The initial discovery of SRX, an ATP-dependent oxidoreductase that reduces cysteine sulfinic acid 14 , ignited interest in S-sulfinylation as a 'redox switch or regulatory modification 11 . Until the present work, 2-Cys PRDX1-4 have remained the only known substrates of SRX, an enzyme that reduces sulfinic acid at their peroxidatic cysteines with concomitant restoration of catalytic activity. Measuring the site-specific turnover of cellular S-sulfinylome, in Supplementary Fig. 22 . Rec, recovery. e, Line-series plot showing the turnover rates of the same S-sulfinylation sites identified in both Srx +/+ and Srx -/-MEFs. f,g, XIC of DiaAlkmodified peptides from PTPN12 (C164) (f) and DJ-1 (C46) (g) from Srx +/+ and Srx -/-MEFs. Heavy (recovery)/light (control) ratios were calculated from two independent experiments and are displayed below the individual chromatograms. h-j, Recombinant SRX1 reduces S-sulfinylation of PTPN12 (h) or DJ-1 (i), but not GAPDH (j), as detected by BioDiaAlk (7 ) . IR 800-Strep, near-infrared dye with maximum excitation at 800 nm, conjugated to streptavidin. Uncropped scans of immunoblots are provided in Supplementary Fig. 22 . k, Luminescence assay measuring SRX1 ATPase activity in the presence of PTPN12 or DJ-1. RLU, relative luminescence units. Signal in the absence of SRX1 was subtracted as background; the control reaction lacked ATP. Representative data from three independent experiments are shown, each performed in triplicate; error bars, s.d.
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NATURe CheMiCAl BiOlOgy the presence and absence of SRX, was made possible by the development of DiaAlk and application to our quantitative chemoproteomic workflow. In total, 59 sites exhibited substantial turnover in Srx +/+ MEFs (R H/L < 0.67) while remaining unchanged or increased (R H/L ≥ 1) in Srx -/-MEFs, thus providing a strong indication that they might be SRX substrates. Additional labeling and biochemical studies with recombinant proteins provided evidence for SRXdependent reduction of S-sulfinylation in both PTPN12 and DJ-1. Our proteomic data are further supported by cell-based studies, which pinpoint C39 as the site of S-sulfinylation in CFL1 and show H 2 O 2 -dependent association of wild-type CFL1 with SRX. This collective work thus identifies new targets of SRX beyond 2-Cys PRDX1-4. This discovery should dramatically accelerate understanding of the role of this antioxidant enzyme in regulating redox balance, circadian rhythms and protein stability, as well as of how its overexpression facilitates survival of cancer cells. The enzymatic reversibility of S-sulfinylation among a cohort of proteins vis-à-vis SRX also reveals a deeper layer of thiol-based redox regulation that was previously unknown. For example, PTPN12, a recently characterized tumor suppressor, is pivotal for regulation of EGFR signaling and is required for embryonic development 50 . S-sulfinylated C164 is directly adjacent to the β 3-loop-β 4 of PTPN12, a structurally diverse region among PTP-PEST family members, which dictates substrate specificity 42 . Likewise, S-sulfinylation mediates a redox switch that enables DJ-1 to participate in cytoprotective signaling under stress 18, 19 . These, and numerous other instances in our datasets, indicate a broader role for individual S-sulfinylation sites in cells.
Finally, it is important to acknowledge some limitations of the current study. In particular, one drawback of our chemoproteomic method is that it is not yet optimized to identify S-sulfinylated cysteines at a global level directly in cells; instead, it is suitable for native proteomes supplemented with antioxidants, including catalase. Therefore, an important future goal will be elaboration of chemoproteomic analysis of S-sulfinylated proteins in situ, including exploration of thiol-blocking tactics with lower cytotoxicity and/or modulation of probe reactivity. Despite these nextgeneration challenges, the current study details a suite of highly enabling and novel chemical probes for unambiguous mapping of S-sulfinylated cysteines and reveals previously undescribed biology through the identification and validation of new SRX substrates. As such, these studies broaden the scope of understanding of cellular 'redox circuitry' and should pave the way for future directions of research to expand knowledge of cysteine hyperoxidation as a regulatory modification in signaling and as a pathological hallmark in human disease.
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Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41589-018-0116-2. 
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Methods General materials and methods. N-Fmoc cysteine, 4-nitrobenzenediazonium tetrafluoroborate, TMAD, diethyl azodicarboxylate, di-isopropyl azodicarboxylate, DBAD, 4-DPS, methyl methanethiosulfonate and iodoacetyl-LC-biotin (IAM-Bio) were purchased from Thermo Fisher. BTD, a clickable probe for detecting S-sulfenylation, and UV-cleavable azide-biotin reagents were synthesized as previously described 2 . Recombinant PTPN12 was purchased from Sino Biological. GAPDH was purchased from Sigma. Reagents and solvents were purchased from Sigma and were used without further purification. For chemical synthesis, all reactions were performed under a nitrogen atmosphere in oven-dried glassware. Analytical thin-layer chromatography was carried out with Analtech Uniplate silica gel plates and visualized with a combination of UV and potassium permanganate staining. Flash chromatography was performed with silica gel (32-63 μ M, 60-Å pore size) from Sorbent Technologies Incorporated. NMR spectra were obtained on a Bruker Avance 400 (400 MHz for 1 H; 100 MHz for 13 C). 1 H and 13 C NMR chemical shifts are reported in parts per million (p.p.m.) referenced to the residual solvent peak. Low-resolution electrospray ionization (ESI) mass spectra were obtained with an Agilent 6120 Single Quadrupole LC-MS instrument.
Antibodies. Antibodies used were HRP-streptavidin (GE Healthcare, RPN1231, 1:80,000), His-tag (Cell Signaling Technologies, 2365, 1:1,000), anti-actin (Santa Cruz Biotechnology, sc-1616 1:1,000), anti-PARK7/DJ-1 (Abcam, ab18257 1:1,000 or Proteintech, 11681-1-AP, 1:500), anti-oxDJ-1 (Millipore, MABN1773, 1:500), anti-PTPN12 (Invitrogen, MA1-12377, 1:2,000), anti-SRX (Santa Cruz Biotechnology, sc-166786, 1:100); anti-NDUFS1 (Abcam, ab169540, 1:5,000); anti-V5 (Invitrogen, R960-25, 1:1,000), anti-HA (Invitrogen, 71-5500, 1:1,000), anti-GAPDH (Abnova, H00002597-M01, 1:1,000), anti-PRDX1 (Abnova, MAB7559, 1:1,000), anti-PRDX2 (Abnova, H00007001-M01, 1:200), rabbit antigoat IgG-HRP (Invitrogen, 31402, 1:20,000 to 1:50,000) and rabbit anti-mouse IgG-HRP (Invitrogen, 61-6520, 1:20,000 to 1:50,000).
Cell lines and culture. A549, HeLa and HEK293T cells were sourced from the ATCC. Srx +/+ and Srx -/-MEFs were kindly provided by S. G. Rhee and M. Toledano. A549, HeLa, HEK293T and MEF cells were cultured in DMEM (Corning) supplemented with 10% (vol/vol) FBS (Invitrogen), 1% (vol/vol) penicillin-streptomycin (Invitrogen) and 1% Glutagro (Corning). Cells were maintained at 37 °C in a 5% CO 2 humidified atmosphere.
Expression and purification of recombinant proteins. C64,82S Gpx3 was expressed and purified as previously described 51 . Wild-type DJ-1, E18N DJ-1 and C106S DJ-1 were expressed and purified as previously described 19 . PspE was expressed and purified as previously described 52 . SRX and PRDX2 were expressed and purified as previously described 43 .
Generation of protein sulfinic acids in vitro.
Recombinant proteins were reduced with DTT (5 mM) for 30 min at 0 °C. Reactions were then passed through one Micro Bio-Spin P-30 column (Bio-Rad) equilibrated with 50 mM HEPES or 100 mM PBS, pH 7.4. DTT-free proteins were then treated with hydrogen peroxide (H 2 O 2 , 2-5 eq.) at room temperature for 1 h. Reactions were quenched by passage through one Micro Bio-Spin P-6 column (Bio-Rad). For C64,82S Gpx3, the reduction-oxidation cycle was repeated to ensure complete reduction of the homodimer. Clarified samples were supplemented with DTT (5 mM), snap frozen in liquid N 2 and stored at − 80 °C. Formation of the sulfinic acid species was confirmed by intact-protein LC-MS analysis, as described below.
Sample preparation for analysis of S-sulfinylation of recombinant proteins.
S-sulfinylated recombinant proteins were incubated with DiaAlk (1 mM) in the dark at room temperature for 1 h. Excess DiaAlk was quenched by incubation with DTT (2 mM) for 30 min and then passed through one Micro Bio-Spin P-30 column preequilibrated with 100 mM PBS, pH 7.4. Click chemistry was performed on buffer-exchanged samples by the addition of 0.1 mM biotin-PEG4-N 3 , 0.25 mM BTTP-CuSO 4 (2:1 ratio) and 2.5 mM ascorbate in 50 mM PBS, pH 7.4, with 100 mM NaCl. After 1 h at room temperature, reactions were quenched with EDTA. Samples were analyzed by immunoblotting, as described below. Equal loading was verified with antibodies against the indicated proteins. were quenched by incubation with DTT (1 mM) for 30 min and passed through one detergent-removal spin column (87777, Pierce) preequilibrated with 100 mM PBS, pH 7.4. Click chemistry was performed on the buffer-exchanged samples, as described above.
Sample preparation for analyzing protein S-sulfinylation
Immunoblotting. Recombinant proteins or cell lysates were separated by SDS-PAGE and semidry transferred to polyvinylidene difluoride (PVDF, 1620177, Bio-Rad). After transfer, the PVDF membrane was blocked with 5% BSA in TBST for 1 h at room temperature. The membrane was washed with TBST (three times) and incubated with indicated primary antibodies overnight at 4 °C. After incubation, the membrane was washed (three times) with TBST and incubated with the appropriate HRP-conjugated secondary antibody. The PVDF membrane was then washed with TBST (three times), visualized by chemiluminescence (ECL Plus, Pierce), exposed to film and analyzed in ImageJ (v1.52) software. SRX reduction of S-sulfinylated proteins was analyzed by transfer onto PVDF-FL (LI-COR). The membrane was then blocked with Odyssey Blocking Buffer (LI-COR) at room temperature for 1 h and probed with the indicated primary antibodies overnight at 4 °C. After incubation, membranes were washed with TBST (three times) and incubated with secondary antibodies (streptavidin 680LT (1:15,000, 925-32230, LI-COR) and goat-anti-mouse/rabbit 800CW (1:15,000, LI-COR, 925-32210/925-32211)) in the dark at room temperature. The membrane was then washed with TBST (three times) and analyzed with an Odyssey Imaging System (LI-COR). For analysis of cellular SRX and S-sulfinylation of DJ-1 and CFL1 from lysates and immunoprecipitates, samples were resolved by SDS-PAGE and transferred to a PVDF membrane (Merck Millipore, IPVH00010), blocked with 5% milk in TBST at room temperature for 1 h and probed with the indicated primary antibodies overnight at 4 °C. After incubation, the membrane was washed with TBST (three times) and incubated with the appropriate HRP-conjugated secondary antibody. The PVDF membrane was then washed with TBST (three times), visualized on a Tanon 5200 scanner and analyzed in GelCap software v 5.6 with ECL chemiluminescence (CWBIO, CW0049S).
Fluorescence imaging. In a four-well chamber slide (Thermo Scientific), 3 × 10 4 HeLa cells were seeded in each compartment. The cells were incubated at 37 °C in a 5% CO 2 atmosphere for 24 h. The cells were then exposed to H 2 O 2 (0, 0.5 or 1 mM) for 15 min and subsequently washed three times with cold PBS containing catalase at 200 U/mL. Cells were then fixed with methanol at − 30 °C for 15 min and permeabilized with 0.2% (vol/vol) Triton X-100 in PBS with iodoacetamide (IAM; 40 mM) in the dark for 1 h. The medium was removed, and each compartment was washed with 0.2% (vol/vol) Triton X-100 in PBS (1 mL, three times). Cells were incubated with DiaFluo (500 µ L, 25 µ M in DMSO) in PBS supplemented with 0.2% (vol/vol) Triton X-100 in the dark at room temperature for 30 min. Subsequently, the medium was removed, and each compartment was washed with PBS containing 0.2% (vol/vol) Triton X-100 (1 mL, four times). After fixation and permeabilization, the cells were incubated with a solution containing DAPI (1 mL, 5 µ g/mL) in PBS in the dark at room temperature for 5 min. The medium was removed, and each compartment was washed with PBS (1 mL, two times), mounted in Fluoromount-G (Thermo Fisher) and imaged by fluorescence microscopy (Olympus FV1000).
Sample preparation for chemoproteomic S-sulfinylome analysis. Cell pellets from A549, HeLa or MEF cells treated with H 2 O 2 (1 mM, 15 min) or left untreated were washed with PBS (three times) and subsequently lysed on ice for 20 min in four volumes of NETN buffer (50 mM HEPES, pH 7.5, 150 mM NaCl and 1% (vol/vol) Igepal) supplemented with HALT protease (10 µ L/mL) and phosphatase inhibitors (Life Technologies, 78444) with catalase (200 U/mL). After a 20-min incubation on ice with frequent mixing, the resulting native proteomes were incubated with 4-DPS (200 mM) at room temperature for 1 h. Excess small molecules were removed by methanol-chloroform precipitation, as described previously 4 . The resulting protein pellets were resuspended in 0.5% (vol/vol) SDS and incubated with DiaAlk (5 mM) in the dark at 37 °C for 2 h. The DiaAlk-labeled proteome was then treated with DTT (8 mM) at room temperature for 1 h. Reduced cysteines were alkylated with IAM (32 mM) in the dark at room temperature for 30 min. Proteins were then precipitated with methanol-chloroform, as previously described 4 . Protein pellets were resuspended in 50 mM ammonium bicarbonate, analyzed with a BCA assay and adjusted to a concentration of 2 mg/mL. Resuspended protein was digested with sequencing-grade trypsin (Promega) at a 1:50 (enzyme/substrate) ratio for 8 h at 37 °C. The tryptic digests were desalted with HLB extraction cartridges (Waters), and the desalted samples were evaporated to dryness under vacuum. Desalted tryptic digests were reconstituted in a solution of 30% acetonitrile at pH ~6. Click chemistry was performed by the addition of 1 mM light or heavy Az-UV-biotin, 10 mM sodium ascorbate, 1 mM TBTA and 10 mM CuSO 4 . Samples were allowed to react with rotation in the dark at room temperature for 2 h. Light and heavy isotopic tagged samples were mixed immediately after click chemistry. Samples were then purified by strong cation-exchange chromatography, as previously described 4 These samples sizes (2) (3) (4) are widely adopted in the field of proteomics. The samples sizes for all other biochemical, imaging, immunoblotting, intact protein MS, and small-molecule MS are reported in the Statistics and Reproducibility section of Online Methods. These sample sizes (3) are widely adopted in the field of chemical biology.
Data exclusions
Describe any data exclusions.
No data was excluded.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
For A549 and HeLa cells, each DiaAlk-based chemoproteomic analysis was performed in three independent experiments with one LC-MS/MS run for each, and each BTD-based chemoproteomic analysis was performed in two independent experiments with two LC-MS/ MS runs for each. For MEF Srx +/+ and MEF Srx -/-cells, each DiaAlk-based chemoproteomic analysis was performed independently twice with two LC-MS/MS runs for each. For each biochemical, immunological and kinetic assay, three independent experiments were performed. The data was very reproducible in all cases and representative data are shown.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomization was not performed because in each chemoproteomic experiment, only two groups of samples under the indicated conditions were compared.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
We used stable isotopic labeling based technology for our quantitative chemoproteomic studies to compare the S-sulfinylome under two different cellular status in parallel. Thus, it was not necessary to design a blinding group allocation.
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
LC-MS/MS Raw data files were processed with the pFind studio (version 3.1.2, http:// pfind.ict.ac.cn/software/pFind3/index.html) for peptide identification and quantification. Dot plots (Fig. 4d, Fig. 5b and Fig. S17 ), bar plots ( Fig S10b, Fig. S16b and Fig. S21c ), bubble plot ( Fig. S15) , Histogram (Fig. 6c ), Line series plots ( Fig. 5a and Fig. 6d ) were generated by OriginPro 9.0.0. Other bar plots ( Fig. 6k and Fig. S19a ) were processed with GraphPad Prism.Venn diagrams ( Fig. 4e and Fig. 5a ) were generated by Excel 2016. Chemical structures were drawn by ChemBioDraw Ultra 14.0. LC-MS/MS Raw data files were processed with the pFind studio (version 3.1.2, http://pfind.ict.ac.cn/software/pFind3/index.html) for peptide identification and quantification. Dot plots (Fig. 4d, Fig. 5b and Fig. S17 ), bar plots ( Fig S10b,  Fig. S16b and Fig. S21c ), bubble plot ( Fig. S15) , Histogram (Fig. 6c ), Line series plots ( Fig. 5a and Fig. 6d ) were generated by OriginPro 9.0.0. Other bar plots ( Fig. 6k and Fig. S19a ) were processed with GraphPad Prism.Venn diagrams ( Fig. 4e and Fig. 5a ) were generated by Excel 2016. Chemical structures were drawn by ChemBioDraw Ultra 14.0. Image J v1.52 (https:// imagej.nih.gov/ij/download.html) or GelCapture v 5.6 software were used image and analyze immunoblot scans.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
We will make the DiaAlk and related probes available to the community under MTA.
